Phase I clinical trials of MRX-115: A new ultrasound contrast agent

Thomas A. Fritz, Evan C. Unger, George Sutherland, David Sahn

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint Dive into the research topics of 'Phase I clinical trials of MRX-115: A new ultrasound contrast agent'. Together they form a unique fingerprint.

Medicine & Life Sciences